MiMedx Group (NASDAQ:MDXG) Stock Rating Lowered by StockNews.com

MiMedx Group (NASDAQ:MDXG) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Wednesday.

Several other analysts have also recently weighed in on MDXG. Cantor Fitzgerald assumed coverage on MiMedx Group in a report on Tuesday. They set an “overweight” rating and a $11.00 price target for the company. Lake Street Capital began coverage on shares of MiMedx Group in a research report on Thursday, March 7th. They set a “buy” rating and a $12.00 price target on the stock. Finally, HC Wainwright reissued a “buy” rating and issued a $11.00 price objective on shares of MiMedx Group in a report on Wednesday, May 1st. Six equities research analysts have rated the stock with a buy rating, According to MarketBeat, MiMedx Group presently has an average rating of “Buy” and an average price target of $12.00.

MiMedx Group Trading Up 0.6 %

Shares of NASDAQ:MDXG opened at $6.82 on Wednesday. The company has a 50-day simple moving average of $7.18 and a 200 day simple moving average of $7.62. The company has a market capitalization of $1.01 billion, a P/E ratio of 15.50 and a beta of 1.99. The company has a debt-to-equity ratio of 0.12, a quick ratio of 2.71 and a current ratio of 3.29. MiMedx Group has a 52-week low of $5.57 and a 52-week high of $9.27.

MiMedx Group (NASDAQ:MDXG) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. The business had revenue of $84.71 million during the quarter, compared to the consensus estimate of $79.36 million. MiMedx Group had a return on equity of 39.42% and a net margin of 18.63%. Sell-side analysts forecast that MiMedx Group will post 0.33 earnings per share for the current year.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in MDXG. AJOVista LLC bought a new stake in MiMedx Group during the 4th quarter worth approximately $25,000. Headlands Technologies LLC acquired a new position in shares of MiMedx Group during the first quarter worth $27,000. Entropy Technologies LP bought a new stake in shares of MiMedx Group in the first quarter worth $99,000. Loudon Investment Management LLC acquired a new stake in MiMedx Group in the fourth quarter valued at $105,000. Finally, KMG Fiduciary Partners LLC bought a new position in MiMedx Group during the 4th quarter worth $105,000. Institutional investors own 79.15% of the company’s stock.

MiMedx Group Company Profile

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins.